Tag: <span>MS therapies</span>

Home / MS therapies
Three MS therapies listed as WHO essential medicines
Post

Three MS therapies listed as WHO essential medicines

by Lindsey Shapiro, PhD | July 27, 2023 For the first time, multiple sclerosis (MS) therapies have been added to the World Health Organization (WHO)’s Model Lists of Essential Medicines (EML), which names those regarded as meeting the most important needs of healthcare systems worldwide. Glatiramer acetate (sold as Copaxone with generics available), Mavenclad (cladribine) and rituximab made the list because of their ability...